Mangoceuticals, Inc. (MGRX) Stock Analysis & Investment Frameworks
Mangoceuticals, Inc. (MGRX) stock analysis on Invetso. Review Mangoceuticals, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Mangoceuticals, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Healthcare Information Services
- Country: US
Mangoceuticals, Inc. Key Financial Metrics
- Market Cap: $4.33M
- Revenue: $456021.00
- ROE: -106.12%
- ROIC: -102.68%
- Dividend Yield: N/A
About Mangoceuticals, Inc.
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Mangoceuticals, Inc. Investment Frameworks
Invetso analyzes Mangoceuticals, Inc. (MGRX) across the following frameworks:
- Mangoceuticals, Inc. 10Y Growth Potential
- Mangoceuticals, Inc. Scenario Analysis
- Mangoceuticals, Inc. Risks & Opportunities
- Mangoceuticals, Inc. Economic Moat
- Mangoceuticals, Inc. Business Model
- Mangoceuticals, Inc. Management
- Mangoceuticals, Inc. SWOT Analysis
- Mangoceuticals, Inc. Porter's 5 Forces
- Mangoceuticals, Inc. PESTLE Analysis
- Mangoceuticals, Inc. ESG Analysis